人参大黄汤联合吴茱萸外敷治疗晚期胃癌临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R735.2

基金项目:


Clinical Study on Renshen Dahuang Decoction Combined with External Application with Euodiae Fructus for Advanced Gastric Cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察人参大黄汤联合吴茱萸外敷对晚期胃癌患者肠胃功能和免疫功能的影响。方法:选取 晚期胃癌患者79 例,根据治疗方法不同分为观察组47 例和对照组32 例。对照组在基础化疗上采取吴茱萸外 敷,观察组在对照组基础上加用人参大黄汤治疗。评价2 组临床疗效,比较2 组首次排气时间、首次排便时 间、肠鸣恢复时间,比较2 组治疗前后胃肠道功能评分(GSRS)、血清中胃动素(MTL)、血管活性肠 肽(VIP)、中医证候评分和T 细胞亚群水平,观察2 组胃肠道并发症及治疗后7、14、28 d 的生活质量评 分(QOL)。结果:观察组胃肠功能恢复优良率高于对照组,差异有统计学意义(P<0.05)。观察组首次排气 时间、首次排便时间、肠鸣恢复时间均短于对照组(P<0.05)。治疗后,2 组GSRS 评分、MTL 水平较治疗前 降低,VIP 水平较治疗前升高(P<0.05);且观察组GSRS 评分、MTL 水平低于对照组,VIP 水平高于对照 组(P<0.05)。治疗后,2 组各项中医证候评分低于治疗前(P<0.05),且观察组各项中医证候评分低于对照 组(P<0.05)。治疗后,2 组CD3+、CD4+、CD4+/CD8+较治疗前升高,CD8+较治疗前降低(P<0.05);且观察 组CD3+、CD4+、CD4+/CD8+水平高于对照组,CD8+水平低于对照组(P<0.05)。观察组治疗后14、28 d 的QOL 评分高于对照组(P<0.05)。观察组胃肠道并发症发生率低于对照组(P<0.05)。结论:人参大黄汤联合吴茱 萸外敷治疗能够有效改善胃癌患者化疗期间胃肠道功能及机体免疫功能,提高生活质量。

    Abstract:

    Abstract: Objective: To observe the effect of Renshen Dahuang Decoction combined with external application with Euodiae Fructus on gastrointestinal function and immune function in patients with advanced gastric cancer. Methods: A total of 79 cases of patients with advanced gastric cancer were selected and divided into the observation group and the control group according to different treatment methods, with 47 and 32 cases in each group respectively. The control group was treated with the external application with Euodiae Fructus based on basic chemotherapy, and the observation group was additionally treated with Renshen Dahuang Decoction based on the treatment of the control group. Clinical effects were evaluated in the two groups. The time of first exhaust,the time of first defecation,the recovery time of borborygmus, the scores of Gastrointestinal Symptom Rating Scale (GSRS), serum motilin (MTL), and vasoactive intestinal peptide (VIP) in serum,traditional Chinese medicine (TCM) syndrome scores and T cell subgroup levels were compared between the two groups before and after treatment. The scores of Quality of Life (QOL) at 7,14,and 28 days after treatment and gastrointestinal complications were observed in the two groups. Results:The excellent and good rate of gastrointestinal function recovery in the observation group was significantly higher than that in the control group,the difference being significant (P<0.05). The time of first exhaust, the time of first defecation, and the recovery time of borborygmus in the observation group were shorter than those in the control group (P<0.05). After treatment,GSRS scores and MTL levels in the two groups were decreased when compared with those before treatment,VIP levels were increased when compared with those before treatment (P<0.05); GSRS scores and MTL levels in the observation group were lower than those in the control group, and the VIP level was higher than that in the control group (P<0.05). After treatment,TCM syndrome scores in the two groups were lower than those before treatment (P<0.05),and the scores in the observation group were lower than those in the control group (P<0.05). After treatment,the levels of CD3+,CD4+,and CD4+/CD8+ in the two groups were increased when compared with those before treatment,and the levels of CD8+ were decreased when compared with those before treatment (P<0.05); the levels of CD3 + , CD4 + , and CD4 +/CD8 + in the observation group were higher than those in the control group,and CD8+ level in the observation group was lower than that in the control group (P<0.05). The QOL scores at 14 and 28 days after treatment in the observation group were higher than those in the control group (P<0.05). The incidence of gastrointestinal complications in the observation group was lower than that in the control group (P<0.05). Conclusion: Renshen Dahuang Decoction combined with external application with Euodiae Fructus can effectively improve gastrointestinal function,immune function and quality of life in patients with advanced gastric cancer during chemotherapy.

    参考文献
    相似文献
    引证文献
引用本文

张文婷,张辉,王春华.人参大黄汤联合吴茱萸外敷治疗晚期胃癌临床研究[J].新中医,2023,55(7):170-174

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-04-12
  • 出版日期: